The protein designated as KIAA1467 homolog in chicken belongs to a family of proteins that remain incompletely characterized across species. In mammals, particularly humans, the corresponding gene is known as FAM234B (family with sequence similarity 234 member B), with KIAA1467 serving as a synonym . The specific identifier "RCJMB04_14d19" represents the unique accession code assigned to this chicken homolog in genomic databases .
The nomenclature reflects the evolutionary conservation of this protein across various species, with homologs identified in multiple vertebrates. The "uncharacterized" designation highlights that despite its conservation, the precise biological functions and molecular mechanisms of this protein remain largely undefined in scientific literature. This classification status is common for numerous genes identified through large-scale sequencing projects that have yet to undergo detailed functional characterization.
The genomic context of the chicken KIAA1467 homolog provides important insights into its potential biological significance. Current research in chicken genomics has revealed tissue-specific expression patterns for numerous genes, including previously uncharacterized proteins. Recent comprehensive studies cataloging highly expressed genes across eight chicken tissues have significantly advanced our understanding of tissue-specific gene expression in chickens .
While specific expression data for KIAA1467 homolog is not directly reported in the available literature, methodologies from recent chicken tissue profiling studies could be applied to determine its expression pattern. Recent research has employed next-generation sequencing to establish repertoires of differentially overexpressed genes (DoEGs) across adult chicken tissues including testis, brain, lung, liver, kidney, muscle, heart, and intestine .
Such comprehensive tissue distribution analysis could potentially reveal whether KIAA1467 homolog belongs to the subset of tissue-specific genes or shows more ubiquitous expression patterns across chicken tissues. This type of analysis would provide valuable clues to its biological functions.
Recent studies analyzing chicken gene families have identified numerous uncharacterized gene families that appear to be specific to avian species. For instance, research has identified eight uncharacterized duplicated paralogs without orthologs in other metazoans except birds, making them specific to chickens/birds . Whether KIAA1467 homolog belongs to such avian-specific gene families remains to be determined.
| Organism | Gene Symbol | Synonyms | Gene ID |
|---|---|---|---|
| Chicken | KIAA1467 homolog | RCJMB04_14d19 | Not specified |
| Human | FAM234B | KIAA1467 | 57613 |
| Cattle | FAM234B | KIAA1467 | 512120 |
Commercial biochemical suppliers offer various products related to KIAA1467 research. For instance, Creative BioMart provides a recombinant chicken KIAA1467 product (catalog number KIAA1467-2040C) . Such commercially available recombinant proteins serve as valuable tools for functional studies, antibody production, and other research applications.
| Product Type | Catalog Number | Supplier |
|---|---|---|
| Recombinant Chicken KIAA1467 | KIAA1467-2040C | Creative BioMart |
| Human KIAA1467 cell lysate | KIAA1467-918HCL | Creative BioMart |
These commercial products enable researchers to conduct comparative studies between human and chicken variants of the protein, potentially revealing evolutionary conservation of structure and function.
While the specific functions of chicken KIAA1467 homolog remain largely unknown, several research approaches could help elucidate its biological roles. Modern genomic and proteomic strategies have proven effective in characterizing previously uncharacterized proteins across species.
Computational approaches leveraging homology with better-characterized proteins in other species represent a valuable starting point for functional prediction. Domain prediction, subcellular localization analysis, and interaction network modeling could provide initial insights into potential functions.
Recent advances in chicken genomics highlight the importance of previously uncharacterized proteins in various biological processes. Research focused on host-microbiota interactions, for example, has revealed numerous genes involved in chicken performance and welfare . Whether KIAA1467 homolog plays a role in such processes warrants investigation.
The "HoloFood" project, which implements hologenomic analyses to understand how host genomic features and microbiota development dynamics shape animal welfare and performance, represents the type of comprehensive approach that could potentially reveal functions of proteins like KIAA1467 homolog . Such research combines multiple omics approaches, including whole-genome sequencing, metagenomics, meta-transcriptomics, and metabolomics.
Comprehensive characterization of the chicken KIAA1467 homolog would require a multi-faceted approach combining various molecular and cellular techniques. The following methodologies represent current best practices for characterizing novel proteins.
Modern multi-omics strategies offer powerful tools for protein characterization. These approaches include:
Genomic analysis to identify regulatory elements and potential binding sites
Transcriptomic profiling across tissues and developmental stages
Proteomic analysis to identify interaction partners
Metabolomic studies to identify affected metabolic pathways
Recent chicken genomics research has demonstrated the value of such integrated approaches in understanding the functions of previously uncharacterized genes .
Experimental approaches to determine the function of KIAA1467 homolog might include:
Gene knockout or knockdown studies using CRISPR-Cas9 or RNA interference
Overexpression studies to identify gain-of-function phenotypes
Protein localization studies using fluorescent tagging
Binding partner identification using co-immunoprecipitation or yeast two-hybrid systems
The evolutionary conservation of KIAA1467 across species suggests functional importance. Comparative analysis between chicken KIAA1467 homolog and its counterparts in other species could provide valuable insights into conserved and species-specific functions.
In humans, the KIAA1467 gene (now known as FAM234B) is located on chromosome 12p13.1 . The human protein (UniProt ID: A2RU67) could serve as a reference point for functional comparison with the chicken homolog . Comparative structural and functional analyses between human and chicken variants could reveal evolutionarily conserved domains and potential functional sites.
Understanding the function of KIAA1467 homolog in chickens could have implications for poultry science, particularly if this protein plays a role in growth, development, or immune response. Chickens are not only important agricultural animals but also serve as valuable model organisms for various biological processes .
Chicken meat is one of the most commonly consumed proteins worldwide, with different cuts providing between 24 and 32 grams of protein per 100 grams . Research into chicken genomics and proteomics has significant implications for improving poultry production and welfare .
The current status of chicken KIAA1467 homolog as an uncharacterized protein presents numerous opportunities for future research. Several promising directions could significantly advance our understanding of this protein.
Detailed expression analysis across tissues, developmental stages, and under various physiological conditions would provide valuable insights into the biological contexts in which this protein functions. Recent studies have already established methodologies for comprehensive gene expression profiling in chicken tissues .
Application of modern functional genomics techniques, including CRISPR-based approaches for gene editing and single-cell RNA sequencing, would enable more precise characterization of KIAA1467 homolog functions. Such approaches have proven effective in elucidating the functions of previously uncharacterized proteins.
Incorporating KIAA1467 homolog studies into broader hologenomic research frameworks, such as those examining host-microbiota interactions, could reveal unexpected functional roles . The interaction between host genomic features and microbiota has emerged as an important factor in animal performance and welfare.
KEGG: gga:417963
UniGene: Gga.13049
The chicken KIAA1467 homolog (RCJMB04_14d19) shares significant sequence similarity with human FAM234B (also known as KIAA1467). While human FAM234B is a protein-coding gene located on chromosome 12 that functions primarily as an integral component of cellular membranes, the chicken homolog likely maintains similar structural domains despite species divergence. Analysis techniques for determining homology include:
Multiple sequence alignment using CLUSTAL or MUSCLE algorithms
Phylogenetic analysis to establish evolutionary relationships
Domain prediction using SMART or PFAM databases
3D structure prediction using homology modeling tools
Experimental verification of functional homology requires expression studies in both species using comparable tissue types, with emphasis on brain tissues where human FAM234B is predominantly expressed .
Human FAM234B is primarily expressed in brain tissues and serves as an integral component of the membrane in various cell types and organs . To determine expression patterns of the chicken homolog:
Methodological approach:
Perform quantitative reverse transcription-polymerase chain reaction (qRT-PCR) across a panel of chicken tissues using primers specific to RCJMB04_14d19
Validate with Western blot analysis using antibodies that cross-react with the chicken protein
Conduct immunohistochemistry on tissue sections for spatial localization
Compare results with human expression data from databases like Human Protein Atlas
Expected findings would likely show whether the chicken homolog maintains tissue-specific expression patterns similar to the human version, particularly in neural tissues. Divergences in expression patterns may suggest species-specific functional adaptations worth further investigation .
When validating antibodies against chicken KIAA1467 homolog for research applications, implementing rigorous controls is essential:
Validation protocol:
Positive controls:
Recombinant chicken KIAA1467 protein at known concentrations
Tissue lysates from regions with predicted high expression (e.g., brain tissues based on human homolog data)
Negative controls:
Tissues from chicken embryos where the gene has been knocked down via CRISPR-Cas9 or siRNA
Pre-absorption of antibody with recombinant protein before use
Secondary antibody-only controls
Cross-reactivity assessment:
Testing against known family members or structurally similar proteins
Testing across species using tissues from different organisms
Validation methods:
Western blotting (expected band size confirmation)
Immunoprecipitation followed by mass spectrometry
Immunohistochemistry with peptide blocking
These validation steps ensure reliable detection and localization in subsequent experiments and prevent misinterpretation of results due to non-specific binding .
Investigating developmental functions requires carefully designed experiments spanning multiple approaches:
Recommended experimental design:
Temporal expression analysis:
Collect embryonic tissues at various developmental stages (e.g., HH stages 5, 10, 15, 20, 25, 30, 35, 40)
Perform qRT-PCR and Western blot analysis for temporal profiling
Generate heat maps of expression changes across developmental timepoints
Loss-of-function studies:
Design CRISPR-Cas9 knockout or morpholino knockdown approaches
Assess phenotypic consequences across three independent replicates
Document developmental abnormalities with detailed imaging
Perform rescue experiments with wild-type protein to confirm specificity
Gain-of-function studies:
Create constructs for overexpression in chicken embryos
Utilize tissue-specific promoters for targeted expression
Compare phenotypes against controls using quantitative metrics
Lineage tracing:
Combine with fluorescent reporters to track expressing cells during development
Perform time-lapse imaging to capture dynamic processes
Each experiment should include at least three biological replicates and appropriate statistical analysis to ensure reproducibility and reliability of findings .
Comparative functional studies require thoughtful experimental designs that address evolutionary conservation while accounting for species-specific differences:
Cross-species experimental strategy:
Expression systems comparison:
Create expression constructs for both chicken KIAA1467 homolog and human FAM234B
Express in comparable neural cell lines from both species
Analyze subcellular localization, interacting partners, and effects on cellular morphology
Rescue experiments:
Establish knockdown/knockout systems for endogenous KIAA1467/FAM234B
Attempt cross-species rescue (human protein in chicken cells and vice versa)
Quantify rescue efficiency using appropriate functional readouts
Domain function analysis:
Generate chimeric proteins swapping domains between species
Assess functionality of each domain in relevant assay systems
Create point mutations in conserved residues to test functional importance
Disease-associated variant studies:
Introduce mutations associated with human neurodevelopmental disorders into conserved regions of chicken homolog
Compare functional consequences across species
Evaluate potential as disease modeling system
This approach allows for determination of functionally conserved regions and species-specific adaptations that may inform the evolution of protein function and disease mechanisms .
Successful recombinant protein production requires meticulous control of multiple variables:
Critical variables to control:
| Variable Category | Specific Variables | Optimization Approach | Measurement Method |
|---|---|---|---|
| Expression Vector | Promoter strength | Test multiple promoters | Expression level quantification |
| Codon optimization | Optimize for expression system | Translation efficiency assessment | |
| Purification tags | Test N-terminal vs C-terminal | Tag interference assays | |
| Expression System | Bacterial (E. coli) | Test multiple strains | Solubility assessment |
| Insect cells | Various cell lines | Post-translational modifications | |
| Mammalian cells | CHO, HEK293, etc. | Functional validation | |
| Induction Parameters | Temperature | 16°C, 25°C, 37°C | Solubility and yield comparison |
| Inducer concentration | Titration series | Dose-response analysis | |
| Duration | Time-course analysis | Optimal harvest time determination | |
| Purification Conditions | Buffer composition | pH, salt, additives | Stability and yield assessment |
| Chromatography methods | Multiple methods | Purity analysis | |
| Storage conditions | Various temperatures | Activity retention |
For membrane-associated proteins like KIAA1467 homologs, additional considerations include detergent selection for solubilization and potential reconstitution into membrane mimetics. Each variable should be systematically tested and optimized through controlled experiments with at least three replicates to ensure reproducibility .
Research into KIAA1467 homolog's disease relevance can be approached through translational methodologies:
Translational research strategy:
Disease model development:
Create chicken embryo models with KIAA1467 mutations corresponding to human disease variants
Develop cell lines with CRISPR-engineered mutations
Assess phenotypic consequences using quantitative metrics
Signaling pathway analysis:
Perform phosphoproteomics to identify altered signaling in mutant vs. wild-type conditions
Conduct RNA-seq for transcriptional changes associated with KIAA1467 dysfunction
Map affected pathways using bioinformatics tools like Ingenuity Pathway Analysis
Functional rescue experiments:
Test therapeutic compounds identified in human studies on chicken models
Evaluate gene therapy approaches using viral vectors
Develop screening systems for identifying novel therapeutic compounds
Biomarker identification:
Identify secreted factors or metabolic changes associated with KIAA1467 dysfunction
Develop detection methods applicable to clinical samples
Validate in multiple experimental systems
Given the association of human FAM234B with neurodevelopmental disorders and recurrent childhood high hyperdiploid acute lymphoblastic leukemia, focusing on analogous conditions in avian models would be most productive .
Membrane protein interaction studies require specialized approaches to maintain native interactions:
Interaction analysis methods:
Proximity-based approaches:
BioID or TurboID proximity labeling with KIAA1467 fusion constructs
APEX2 proximity labeling for temporal control
Split-reporter complementation assays (BiFC, SRET)
Analysis by mass spectrometry to identify proximal proteins
Co-immunoprecipitation methods:
Crosslinking-assisted immunoprecipitation using membrane-permeable crosslinkers
Digitonin or other mild detergent solubilization protocols
Tandem affinity purification with quantitative proteomics
Comparison of interactome under various cellular conditions
Advanced microscopy:
FRET/FLIM for direct interaction detection
Super-resolution microscopy for spatial co-localization
Single-molecule tracking to assess dynamic interactions
Correlative light and electron microscopy for ultrastructural context
Functional validation:
Mutagenesis of interaction interfaces
Competition assays with peptide mimetics
Functional readouts to assess biological relevance of interactions
Each approach has strengths and limitations, so combining multiple methods provides the most comprehensive and reliable interaction map .
When facing contradictory results, systematic troubleshooting and reconciliation approaches are essential:
Data reconciliation strategy:
System-specific variation analysis:
Directly compare experimental conditions across studies (cell types, developmental stages, assay conditions)
Test protein function across multiple systems in parallel using standardized protocols
Quantify expression levels and protein modifications in each system
Create a comparative table of system-specific variables that may influence outcomes
Isoform and splice variant investigation:
Perform 5' and 3' RACE to identify all potential transcript variants
Specifically target each variant in functional assays
Quantify relative abundance of variants across tissues and conditions
Test functional complementation between variants
Post-translational modification mapping:
Use mass spectrometry to identify modifications across systems
Create modification-specific mutants (phosphomimetic, etc.)
Test functional consequences of each modification
Develop modification-specific antibodies for tracking
Contextual dependency experiments:
Systematically vary cellular context (confluence, cell cycle stage, stress conditions)
Test combinatorial effects with known interacting partners
Develop mathematical models to predict context-dependent functions
Validate predictions experimentally
This systematic approach can identify conditional factors that explain apparent contradictions and lead to a more nuanced understanding of protein function .
Evolutionary analysis provides powerful insights into protein function through conservation patterns:
Evolutionary analysis workflow:
Sequence acquisition and alignment:
Obtain KIAA1467/FAM234B sequences from diverse species (mammals, birds, reptiles, amphibians, fish)
Perform multiple sequence alignment using MUSCLE or T-Coffee
Visualize alignments using JalView or similar tools with conservation scoring
Conservation analysis:
Calculate site-specific evolutionary rates using programs like Rate4Site
Identify ultra-conserved regions across distant species
Map conservation scores onto predicted secondary structures
Identify lineage-specific accelerated evolution regions
Functional domain prediction:
Correlate conservation patterns with predicted domains from Pfam/SMART
Identify conserved motifs using MEME or similar tools
Map known disease-causing mutations onto conservation patterns
Predict functional importance based on evolutionary constraint
Experimental validation:
Design deletion constructs based on conservation boundaries
Create chimeric proteins exchanging domains between distant homologs
Test functionality of conserved motifs through targeted mutagenesis
Correlate evolutionary predictions with experimental outcomes
| Species Group | Conservation Score (0-1) | Predicted Functional Importance |
|---|---|---|
| Mammals | 0.85-0.95 | Critical core functions |
| Birds | 0.80-0.90 | Vertebrate-specific functions |
| Reptiles | 0.75-0.85 | Amniote-specific functions |
| Amphibians | 0.60-0.75 | Tetrapod-specific functions |
| Fish | 0.50-0.65 | Vertebrate innovations |
| Invertebrates | 0.30-0.45 | Ancient ancestral functions |
These analyses provide a framework for prioritizing regions for detailed functional characterization .
Robust statistical analysis of expression data requires appropriate methods for biological variation:
Statistical analysis protocol:
Data preprocessing:
Normalize qRT-PCR data using validated reference genes (GAPDH, β-actin, and 18S rRNA)
Apply appropriate transformations (log2) for variance stabilization
Perform quality control to identify and handle outliers
Test for normality using Shapiro-Wilk or similar tests
Comparative analysis:
For comparing expression across tissues: ANOVA with post-hoc tests (Tukey's HSD)
For developmental time-course: repeated measures ANOVA or mixed models
For comparing disease vs. normal: t-tests or non-parametric alternatives
Calculate fold changes with confidence intervals
Advanced statistical approaches:
Principal Component Analysis for identifying tissue-specific patterns
Hierarchical clustering for identifying co-regulated genes
Correlation analysis with phenotypic measures
Multiple testing correction (Benjamini-Hochberg) for genome-wide comparisons
Visualization techniques:
Heat maps for multi-tissue comparisons
Box plots showing distribution of expression values
Violin plots for comparing distributions across conditions
Forest plots for comparing effect sizes across experiments
Sample analysis workflow should include at least three biological replicates per condition, with appropriate adjustment for technical variation using standardized quality controls .
Differentiating specific from non-specific effects requires carefully designed controls and validation experiments:
Specificity validation strategy:
Multiple targeting approaches:
Use different siRNA/shRNA sequences targeting distinct regions
Compare CRISPR-Cas9 knockout with RNAi knockdown
Create conditional systems (tet-inducible, etc.) to control timing
Compare phenotypes across all approaches for consistency
Rescue experiments:
Re-express RNAi-resistant wild-type protein
Create structure-function rescue panel with domain deletions
Use orthologous genes from distantly related species for rescue
Quantify rescue efficiency with dose-response analysis
Off-target assessment:
Perform RNA-seq to identify transcriptome-wide changes
Use non-targeting controls with similar chemical properties
Include scrambled sequence controls
Test for effects on closely related family members
Phenotypic specificity analysis:
Develop a phenotypic signature panel of multiple readouts
Compare to known phenotypes of related genes
Test epistatic relationships with interaction partners
Use mathematical modeling to predict specific pathway effects
Based on human FAM234B associations with neurodevelopmental disorders, several research avenues warrant investigation:
Neurodevelopmental research approaches:
Neural cell fate specification:
Track KIAA1467 expression in neural progenitor cells during chicken embryo development
Manipulate expression in neural crest cells and neural tube
Assess effects on neuronal subtypes and glia formation
Quantify changes in neural differentiation markers
Axon guidance and synaptogenesis:
Visualize KIAA1467-expressing neurons during circuit formation
Analyze axon pathfinding in KIAA1467 knockdown models
Quantify synapse formation using electrophysiology and imaging
Test for interactions with known guidance molecules
Cellular membrane dynamics:
Investigate KIAA1467's role in neuronal migration
Analyze membrane protein trafficking in developing neurons
Examine effects on dendrite formation and arborization
Quantify spine morphology in mature neurons
Electrophysiological properties:
Record electrical activity in neurons with altered KIAA1467 levels
Measure synaptic transmission parameters
Analyze network formation in neuronal cultures
Test for seizure susceptibility in whole-embryo models
Research should focus on comparative analysis with human neurodevelopmental conditions to identify conserved mechanisms that might inform therapeutic approaches .
Given associations of FAM234B with lymphoblastic leukemia in humans, investigating immune system roles requires specialized approaches:
Immune system investigation methods:
Hematopoietic cell development:
Track KIAA1467 expression in developing blood lineages
Perform colony formation assays with manipulated expression
Analyze lineage commitment using flow cytometry
Test effects on progenitor self-renewal and differentiation
Immune cell function:
Assess impact on cytokine production and inflammatory responses
Measure phagocytic activity in myeloid cells
Analyze migration and chemotaxis
Test antigen presentation and T cell activation
Signaling pathway integration:
Investigate cross-talk with established immune signaling pathways
Analyze phosphorylation cascades in immune cells
Test for interactions with immune receptors
Map signaling networks using proteomics approaches
In vivo models:
Create chimeric embryos with KIAA1467-modified hematopoietic cells
Challenge with immune stimulants to assess functional consequences
Analyze thymic and bursal development in manipulated embryos
Track long-term lineage development using barcoding approaches
This systematic approach will determine whether KIAA1467's association with leukemia reflects a fundamental role in immune development or a pathological mechanism specific to disease states .
Translating findings from chicken models to human disease applications requires strategic approaches:
Translational research framework:
Comparative disease modeling:
Identify human conditions with KIAA1467/FAM234B involvement
Create parallel chicken models with equivalent genetic modifications
Compare phenotypes across species at cellular and physiological levels
Validate molecular mechanisms across species
Drug screening and development:
Establish cell-based assays suitable for high-throughput screening
Screen compound libraries for modulators of KIAA1467 function
Validate hits in increasingly complex systems (cells → embryos → animal models)
Test successful candidates in human cell models
Biomarker development:
Identify conserved downstream effectors altered in disease states
Develop detection methods applicable to clinical samples
Validate in multiple experimental systems and species
Test correlation with disease progression and treatment response
Gene therapy approaches:
Develop viral vectors for correcting KIAA1467 dysfunction
Test delivery methods in chicken embryo models
Assess long-term expression and functional correction
Translate successful approaches to mammalian models
This coordinated approach leverages the accessibility and manipulability of the chicken model while maintaining focus on human health applications .
Current research reveals several critical knowledge gaps that warrant prioritization:
Basic structural and biochemical characterization of the chicken KIAA1467 homolog protein
Comparative analysis of tissue expression patterns between chicken and mammalian homologs
Identification of protein interaction partners specific to avian systems
Determination of subcellular localization and trafficking mechanisms
Elucidation of developmental roles in neural and immune system development
Researchers should initially focus on establishing fundamental characteristics before proceeding to more complex functional studies. Collaborative approaches combining structural biology, developmental biology, and systems-level analyses will be most effective in addressing these knowledge gaps comprehensively .
To enhance reproducibility and facilitate cross-laboratory validation, these standardized protocols are recommended:
Protein expression and purification protocol with detailed buffer compositions and quality control metrics
Validated antibody characterization and immunodetection procedures
Standardized embryonic manipulation techniques with precise staging criteria
Cell culture systems optimized for KIAA1467 functional studies
Data reporting templates that include all relevant experimental parameters
Each protocol should specify minimum requirements for biological replicates, positive and negative controls, validation criteria, and statistical approaches. These standards will accelerate research progress by allowing direct comparison of results across different research groups .
Effective integration of diverse scientific disciplines requires coordinated approaches:
Establish research consortia with expertise spanning structural biology, developmental biology, immunology, and neuroscience
Develop shared resources including antibodies, expression constructs, and animal models
Create common bioinformatic pipelines for data analysis and integration
Implement regular data sharing and collaborative experimental design
This multidisciplinary framework ensures comprehensive characterization from molecular mechanisms to organismal functions, maximizing research efficiency and accelerating discovery .